Results 111 to 120 of about 16,883 (239)

1279. Real World Treatment Experience of Treatment-Naïve People with HIV who Initiated Treatment with Single Tablet Dolutegravir/Lamivudine in a Test and Treat setting in the US.

, 2022
Jennifer Kuretski, Cindy Donovan, Gavin Harper, Deanna Merrill, Katie Mycock, Alan Oglesby, Aimee A Metzner, Jimena Patarroyo   +7 more
openalex   +1 more source

Virological Suppression and Its Associated Factors of Dolutegravir Based Regimen in a Resource-Limited Setting: An Observational Retrospective Study in Ethiopia

, 2021
Eden Abetu Mehari, Esileman Abdela Muche, Kedir Abdela Gonete   +2 more
openalex   +2 more sources

Effectiveness of dolutegravir-based treatment among HIV/AIDS patients in Nkembo Outpatient Treatment Center, Gabon

AIDS Research and Therapy
Background HIV/AIDS therapy continues to make an enormous contribution to improving the well-being of HIV/AIDS patients globally. In Gabon, dolutegravir is administered to HIV/AIDS patients from first-line treatment.
Christian Mangala, Rolf Moukanda-Ifoundou, Denis Maulot-Bangola, Alain Moutsinga, Christian Mombo-Maganga, Serge Christian Okolongo-Mayani, Brice Ongali, Guy Joseph Lemamy, Rachyda Massolou-Outata   +8 more
doaj   +1 more source

Metabolic implications and safety of dolutegravir use in pregnancy [PDF]

, 2023
Valeriya Dontsova, Haneesha Mohan, Camille Blanco, Jennifer Jao, Nicholas D. E. Greene, Andrew J. Copp, Rebecca Zash, Lena Serghides   +7 more
openalex   +1 more source

Potential benefit of dolutegravir once daily: efficacy and safety

HIV/AIDS: Research and Palliative Care, 2013
Alessandra Fantauzzi,1 Ombretta Turriziani,2 Ivano Mezzaroma11Department of Clinical Medicine, 2Department of Molecular Medicine, Sapienza, University of Rome, Rome, ItalyAbstract: The viral integrase enzyme has recently emerged as a primary alternative ...
Fantauzzi A, Turriziani O, Mezzaroma I
doaj  

Brief communication: Long-term treatment outcomes of transitioning to dolutegravir-based ART from efavirenz in HIV study participants in Mbeya, Tanzania

AIDS Research and Therapy
Background The World Health Organization recommends dolutegravir-based antiretroviral therapy (ART) as the preferred first-line regimen for HIV treatment.
Revocatus T. Majula, Clement N. Mweya
doaj   +1 more source

Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir-Containing and Tenofovir-Containing Regimens

, 2021
Zinhle Cindi, Gary Maartens, Yuki Bradford, François Venter, Simiso Sokhela, Nomathemba Chandiwana, David W. Haas, Phumla Sinxadi   +7 more
openalex   +2 more sources

Drug–drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model [PDF]

, 2022
Aida N. Kawuma, Roeland E. Wasmann, Kelly E. Dooley, Gary Maartens, Paolo Denti   +4 more
openalex   +1 more source

7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir [PDF]

, 2018
Robert Ziegler, Bimbisar Desai, Jo‐Ann Jee, B. Frank Gupton, Thomas D. Roper, Timothy F. Jamison   +5 more
openalex   +1 more source

¿La combinación dolutegravir y rifampicina en los pacientes no incluidos en los ensayos clínicos es también eficaz y segura en el binomio VIH-infección micobacteriana? Casos de la práctica clínica

Medicina Clínica Práctica
Resumen: Introducción: las infecciones micobacterianas (IM) y la infección por VIH (iVIH) siguen siendo un binomio frecuente. La rifampicina dificulta el uso de los antirretrovirales.
Sara Fontserè Recuenco, Rafael Luque-Márquez   +1 more
doaj   +1 more source